Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using simvastatin to protect the heart during cardiac surgery

Official title: A Study of Simvastatin on Myocardial Protection and Cardiac Function Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Run by Sun Yat-sen University · NCT01653223 · Data updated 2026-11-12

This study tests if simvastatin can help protect the heart and improve recovery for patients having cardiac surgery for heart defects or valve problems.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment369 (estimated)
SponsorSun Yat-sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedJanuary 2013
Main results expectedDecember 2024
Study endsDecember 2026
Registry record updatedApril 21, 2023
Trial IDNCT01653223 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 with congenital heart disease or isolated heart valve disease.

Probably not a fit

Patients with coronary artery disease or those allergic to statins will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the myocardial protection effects of simvastatin in patients undergoing cardiac surgery for congenital heart disease and isolated heart valve disease. The research aims to determine whether simvastatin can reduce myocardial injury and improve cardiac function during and after surgery, particularly in cases involving cardiopulmonary bypass. Conducted at two medical centers, this interventional study will assess the long-term benefits of simvastatin postoperatively.

Why it matters

Potential benefit: If successful, this approach could lead to improved heart function and reduced complications for patients undergoing cardiac surgery.

How similar studies have gone: Previous studies have indicated that statins may provide myocardial protection, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* More than 18-year-old,
* Congenital heart disease(not complex),
* Isolated heart valve disease,

Exclusion Criteria:

* Coronary artery disease
* Allergy for statins
* Poor liver function,Hepatitis
* Gestation women and Breast-feeding women

Where it's running

  • The First Affiliated Hospital, Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

  • Principal investigator: Jing-song Ou, MD,PhD — The Frist Affiliated Hospital, Sun Yat-sen University
  • Study coordinator: Jing-song Ou, MD, PhD
  • Email: oujs2000@yahoo.com
  • Phone: 8620-87755766

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.